Li et al. [5] identified carcinoembryonic antigen as an established biomarker for lung carcinoma detection, though its full clinical potential remained unrealized due to limitations in current analytical methodologies regarding sensitivity and dynamic range. Here, CEACAM5 is linked to lung carcinoma.